Menu

My Favorite Moment at ASH 2015

| Carlene Pratt

I thoroughly enjoyed hearing Dr. Brian Durie’s abstract presentation on “Myeloma: Therapy, excluding Transplantation: Advances in Newly Diagnosed and Relapsed Myeloma.”  He presented that the combination of VELCADE® (bortezomib), Revilmid® (lenalidomide), and dexamethasone (also called VRd), with continuous maintenance of lenalidomide and dexamethasone significantly improves progression-free survival and overall survival. This VRd regimen along with […]

My First Day at ASH 2015

| Carlene Pratt

On the first day at ASH 2015, all the other Support Group Leaders and I walked into the Hyatt Regency Orlando. Immediately, I noticed the Christmas trees decorated nicely and the smell of poinsettias. We were able to gather around the Christmas trees and take a group picture. After seeing the diverse crowds of people walking in every direction […]

Research Grant Reception

| Carlene Pratt

The Research Grant Award Reception last night was very inspirational and enlightening. I loved hearing each of the patients tell their own personal stories about their initial diagnosis and how they live with multiple myeloma. As a patient myself, I know how lost and alone you can feel with the initial diagnosis. Each one of […]

First-timer at ASH: Excited to Share With You

| Carlene Pratt

Each year in December, ASH Annual Meeting and Exposition brings hematologists from all over the world together, creating a forum to discuss and share critical issues in hematology today. This will be my first attendance to the American Society of Hematology 57th Annual Meeting and Exposition. I’ve been told that nearly 25,000 clinicians, doctors, scientists, […]